Recently added articles from Biotech Financial Reports:
SUPERGEN HAS 2009 3RD QTR TOTAL REVENUES OF $10.4 MILLION.(Financial report)
Dec 01, 2009 ... SuperGen, Inc. (NASDAQ:SUPG), Dublin, Calif. reported financial results for the third quarter and nine months ended September 30, 2009. Total revenues for the 2009 third quarter were $10.4 million, compared with $10.2 million for the same prior year period. Total revenues for the 2009 ...
BIOCUREX SHAREHOLDERS INCREASE CAPITALIZATION AND CHANGE NAME.(Whispering Oaks International, Inc.)(Antonia Bold de Haughton)
Dec 01, 2009 ... Whispering Oaks International, Inc., d/b/a BioCurex (OTCBB:BOCX), Richmond, B.C., Canads, has announced that at a special meeting of shareholders , its shareholders overwhelmingly approved the proposals to change its legal name to BioCurex, Inc. and to increase the company's capitalization ...
DYNAX CORP. REPORTS 3RD QTR NET LOSS OF $12.2 MILLION.(Financial report)
Dec 01, 2009 ... Dyax Corp. (NASDAQ: DYAX), Cambridge, Mass., has announced financial results for the third quarter ended September 30, 2009. Total revenues for the third quarter ended September 30, 2009 were $4.5 million, as compared to $5.5 million for the comparable quarter in 2008. Total ...
PATHWAY MEDICAL HAS 172% GROWTH OVER LAST 2 QUARTERS.(Pathway Medical Technologies Jetstream G2 NXT)
Nov 01, 2009 ... Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), has announced a 172 percent growth over the last two quarters with its Jetstream peripheral revascularization catheters at more than 150 centers of excellence in the United ...
OPEXA TRIGGERS MILESTONE PAYMENT UNDER STEM CELL PACT.
Nov 01, 2009 ... Opexa Therapeutics, Inc. (NASDAQ:OPXA),The Woodlands, Texas, a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), has announced that it has achieved its first technology transfer milestone in connection with the company's recently announced ...